Renseignements généraux

Nº de série

S/O

Nº de partie

1

Nombre total de parties

2

Ou

poster paper

Brevets

S/O

Description générale

paper

Dimensions

Remarque : Cette information reflète la taille générale pour l’entreposage et ne représente pas nécessairement les véritables dimensions de l’objet.

Longueur

129,0 cm

Largeur

91,5 cm

Hauteur

S/O

Épaisseur

S/O

Poids

S/O

Diamètre

S/O

Volume

S/O

Lexique

Groupe

Technologie médicale

Catégorie

Archives

Sous-catégorie

S/O

Fabricant

Ou

Ottawa Hospital

Pays

Canada

État/province

Ontario

Ville

Ottawa

Contexte

Pays

Canada

État/province

Québec

Période

This poster believed produced c. 2009. This example was displayed at the Canadian Stem Cell Conference in 2009.

Canada

An August 2010 report in Science Translational Medicine, about the preliminary success of clinical implantations of biosynthetic corneas made in Canada, was picked up by main-stream news organizations around the world in late August 2010 making it one of the most covered Canadian medical stories of the year. Synthetic and natural corneas have been implanted into humans for years. It is now a routine surgery with a variety of techniques and materials. The corneas in this acquisition represent a new development in this history, the use of bio-engineered materials for making the corneas. This material derives from recombinant human collagen, which is shaped and "forged" into biosynthetic corneas for implantation into humans. The implants are more accurately called "biomimetic" because the resulting implants mimic cell growth and restoration of natural cornea without the risk of rejection. The initial human trials were successful (reported in 2010, see references below), but this technique is still in the prototype phase with more engineering being developed. This development also represents new trends in laboratory medicine - close partnerships between genome-based biotechnology industries, hospital research institutes and laboratories.

Fonction

To present images and information together in large format.

Technique

Inconnu

Notes sur la région

Inconnu

Détails

Marques

Markings include "A Regenerative Medicine Approach to Corneal Transplantation/ Phase 1 Clinical Trial Results/ Kim Merrett 1*, Per Fagerholm*, Neil Lagali, Dave Carlsson, Frank Li, and May Griffith/ 1 Department of Cellular and Molecular Medicine, University of Ottawa, University of Ottawa Eye Institute, Ottawa, Ontario K1H 8M5, Canada/ * denotes equal contributions" [title]; "Abstract", "Objectives", "Methods", "Results and Discussion", and "Summary" [text headings] and illustrations; and "Acknowledgements/ We thank Dr. Bruce Jackson for his input during this study; Cooper Vision for the/ fabrication of the corneal implants for the Phase 1 clinical study; and various other/ colleagues in Ottawa, the EU and Japan for their previous, invaluable contributions to this/ project. The study was supported by grants from the Swedish Research Council and the/ County of Ostergotland to PF and the Canadian Stem Cell Network to MG." "2009/ Canadian Stem Cell/ Conference, Montreal" handwritten [by Dr. R.C. Brooks] in black ink on reverse.

Manque

None.

Fini

Glossy paper poster is predominantly blue, with black-and-white and colour images, and black and white text.

Décoration

Logos of Ottawa Hospital Research Institute, University of Ottawa and Ottawa Eye Institute appear on poster.